Literature DB >> 17963065

Pelvic floor sex steroid hormone receptors, distribution and expression in pre- and postmenopausal stress urinary incontinent women.

Marie Westergren Söderberg1, Bengt Johansson, Britt Masironi, Birgitta Byström, Christian Falconer, Lena Sahlin, Gunvor Ekman Ordeberg.   

Abstract

BACKGROUND: Hormonal influence on stress urinary incontinence (SUI) is under debate. Sex steroid hormonal activity is mediated by nuclear receptor proteins. The aim of this study is to identify receptor isoforms and their genetic expression in the pelvic floor extra cellular matrix (ECM), and to compare women with and without SUI before and after menopause.
METHODS: Sub-mucosal para-urethral biopsies from 4 pre-menopausal and 8 postmenopausal patients with SUI were analysed immunohistochemically regarding estrogen receptors (ER) alpha and beta, the progesterone receptor (PR) (A+B) and B, and the androgen receptor (AR). Six pre-menopausal and 5 postmenopausal women served as controls. All receptors were scored manually. Additionally, ER-alpha and ER-beta were quantified by image analysis. Biopsies from 7 pre-menopausal and 7 postmenopausal women suffering from SUI were studied by real-time RT-PCR for expression of ER-alpha, ER-beta, PR and AR. The control group consisted of 5 pre-menopausal and 5 postmenopausal women.
RESULTS: Immunohistochemistry revealed receptor-positive cells for all isoforms in all groups. Higher ER-beta scores were seen in the pre-menopausal SUI group compared to controls. Lower PR-B scores were found after menopause in both groups. The image analysis confirmed that ER-beta was significantly increased in the pre-menopausal SUI group compared to controls (p=0.02). By real-time RT-PCR, no difference of mRNA expression regarding any receptor was detected between any SUI and control group. ER-beta mRNA levels were low or undetectable. There was a significant down-regulation of PR among postmenopausal women (p=0.001).
CONCLUSIONS: The para-urethral ECM is a target for sex steroid hormones mediated by the respective receptor. The significant higher expression of ER-beta protein in the pre-menopausal SUI-group was not reflected by a corresponding up-regulation of mRNA which was poorly expressed in all groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963065     DOI: 10.1080/00016340701625446

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  Proteomic analysis of pubocervical fascia in women with and without pelvic organ prolapse and urodynamic stress incontinence.

Authors:  Stavros Athanasiou; Elias Lymberopoulos; Sofia Kanellopoulou; Alexandros Rodolakis; George Vlachos; Aris Antsaklis
Journal:  Int Urogynecol J       Date:  2010-06-23       Impact factor: 2.894

Review 2.  Treating menopause - MHT and beyond.

Authors:  Susan R Davis; Rodney J Baber
Journal:  Nat Rev Endocrinol       Date:  2022-05-27       Impact factor: 47.564

3.  Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register.

Authors:  Anastasia Iliadou; Ian Milsom; Nancy L Pedersen; Daniel Altman
Journal:  Fertil Steril       Date:  2008-08-15       Impact factor: 7.329

Review 4.  Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women.

Authors:  Irwin Goldstein; Brian Dicks; Noel N Kim; Rose Hartzell
Journal:  Sex Med       Date:  2013-12       Impact factor: 2.491

5.  Effectiveness of hormones in postmenopausal pelvic floor dysfunction-International Urogynecological Association research and development-committee opinion.

Authors:  Barbara Bodner-Adler; May Alarab; Alejandra M Ruiz-Zapata; Pallavi Latthe
Journal:  Int Urogynecol J       Date:  2019-08-07       Impact factor: 2.894

Review 6.  Molecular Processes in Stress Urinary Incontinence: A Systematic Review of Human and Animal Studies.

Authors:  Wilke M Post; Joanna Widomska; Hilde Grens; Marieke J H Coenen; Frank M J Martens; Dick A W Janssen; Joanna IntHout; Geert Poelmans; Egbert Oosterwijk; Kirsten B Kluivers
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.